03320 華潤醫藥
公司資料 - 損益表
華潤醫藥集團有限公司 股票編號: 03320
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED 集團網址: http://www.crpharm.com
2024/12 - 末期
人民幣(K¥)
變動 2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
營業額 / 收益257,673,2565.300%244,703,884218,182,994193,611,454168,677,851
銷售成本(216,984,387)5.145%(206,366,398)(184,563,943)(164,684,722)(141,499,042)
毛利40,688,8696.133%38,337,48633,619,05128,926,73227,178,809
 
投資物業公平值變動及減值------------
其他項目公平值變動及減值------------
出售項目溢利 / (虧損)------------
其他非經營項目------------
分佔聯營公司及共同控制公司業績368,014-11.770%417,106332,341256,395174,089
除稅前溢利 / (虧損)10,929,92210.624%9,880,2278,361,0816,874,6895,954,812
稅項(2,526,679)20.019%(2,105,224)(1,703,152)(1,439,805)(1,474,387)
已終止經營業務溢利 / (虧損)------------
非控股權益(5,052,386)28.863%(3,920,756)(3,157,659)(2,353,460)(1,705,534)
其他項目------------
股東應佔溢利 / (虧損)3,350,857-13.061%3,854,2473,500,2703,081,4232,774,891
 
淨財務支出 / (收入)1,600,779-11.000%1,798,6261,732,2891,647,7412,085,093
折舊及攤銷3,356,7106.078%3,164,3652,558,4412,307,1622,056,937
董事酬金8,7448.111%8,08811,22410,9777,662
 
核數師意見無保留意見--無保留意見無保留意見無保留意見無保留意見
 
市場價值指標
每股盈利 (仙)53.000--61.00056.00049.05643.764
每股派息 (仙)13.500--15.40014.29212.26410.099
派息比率 (%)25.472%--25.246%25.522%25.000%23.077%
每股現金流 ($)----2.4751.7221.6711.099
每股帳面資產淨值 ($)7.679--7.3156.9336.6356.225
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.